---
title: "Ustekinumab - Psoriasis"
sidebar: mydoc_sidebar
permalink: db05679-mesh-d011565-1.html
toc: false 
---


Path ID: `DB05679_MESH_D011565_1`
{% include image.html url="images/db05679-mesh-d011565-1.png" file="db05679-mesh-d011565-1.png" alt="db05679-mesh-d011565-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000069549 | ustekinumab | Drug |
| UniProt:P29460 | Interleukin-12 subunit beta | Protein |
| GO:0035722 | interleukin-12-mediated signaling pathway | BiologicalProcess |
| GO:0038155 | interleukin-23-mediated signaling pathway | BiologicalProcess |
| GO:0006954 | inflammatory response | BiologicalProcess |
| MESH:D011565 | Psoriasis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ustekinumab | DECREASES ACTIVITY OF | Interleukin-12 Subunit Beta |
| Interleukin-12 Subunit Beta | POSITIVELY REGULATES | Interleukin-12-Mediated Signaling Pathway |
| Interleukin-12 Subunit Beta | POSITIVELY REGULATES | Interleukin-23-Mediated Signaling Pathway |
| Interleukin-12-Mediated Signaling Pathway | POSITIVELY REGULATES | Inflammatory Response |
| Interleukin-23-Mediated Signaling Pathway | POSITIVELY REGULATES | Inflammatory Response |
| Inflammatory Response | POSITIVELY CORRELATED WITH | Psoriasis |
|---------|-----------|---------|

Comment: This drug binds to the p-40 subunit (UniProt:P29460) of both IL-12 (UniProt:P29459) and IL-23 (UniProt:Q9NPF7) so that they subsequently cannot bind to their receptors (https://en.wikipedia.org/wiki/Ustekinumab#Mechanism_of_action).

Reference: 
  - [https://go.drugbank.com/drugs/DB05679](https://go.drugbank.com/drugs/DB05679)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201835/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201835/)
